GSK reports promising early results in ovarian and womb cancer drug trial

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

T theguardian.com

What’s included

Top recent items from this story.

1 items • 1 unique links

The Guardian - UK 22 hours ago • theguardian.com

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drugGSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels, seeks…

Open